GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

CEO

W. Marc Hertz

Employees

Country

United States

ISIN

US3622AW5029

Listings

0 Comments

Share your thoughts

FAQ

What is GRI Bio stock price today?▼

The current price of GRI is $1.72 USD — it has increased by +0.58% in the past 24 hours. Watch GRI Bio stock price performance more closely on the chart.

What is GRI Bio stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange GRI Bio stocks are traded under the ticker GRI.

Is GRI Bio stock price growing?▼

GRI stock has fallen by -12.31% compared to the previous week, the month change is a +14% rise, over the last year GRI Bio has showed a -95.7% decrease.

What is GRI Bio market cap?▼

Today GRI Bio has the market capitalization of 3.03M

When is the next GRI Bio earnings date?▼

GRI Bio is going to release the next earnings report on November 18, 2026.

What is GRI Bio revenue for the last year?▼

GRI Bio revenue for the last year amounts to 0 USD.

What is GRI Bio net income for the last year?▼

GRI net income for the last year is -11.96M USD.

How many employees does GRI Bio have?▼

As of August 19, 2026, the company has 5 employees.

In which sector is GRI Bio located?▼

GRI Bio operates in the Health & Wellness sector.

When did GRI Bio complete a stock split?▼

The last stock split for GRI Bio was on January 26, 2026 with a ratio of 1:28.

Where is GRI Bio headquartered?▼

GRI Bio is headquartered in LA JOLLA, United States.